BIOREGULATOR ANTI AGING OÜ
Date of report 18.03.2025
Open the reports you want to print
Employees and salaries
BIOREGULATOR ANTI AGING OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
BIOREGULATOR ANTI AGING OÜ
Decision-makers?
Former decision-makers
Relations: 1
Turnover:
Employees:
Werner Günter Ulrich
★★★★
......
Credit Score: Trustworthy
Reputation score: 1210
Date of birth: ......
Active relations 1
*Every member of the management board may represent the private limited company in concluding all transactions.
BIOREGULATOR ANTI AGING OÜ
Former decision-makers?
Relations: 45
Turnover 2024: 58 035 €
Employees: 3
Liis Männiste
★★★★
......
Credit Score: Trustworthy
Reputation score: 7900
Date of birth: ......
Active relations 45
Relations: 45
Turnover 2024: 58 035 €
Employees: 3
Liis Männiste
★★★★
......
Credit Score: Trustworthy
Reputation score: 7900
Date of birth: ......
Active relations 45
2024 IV quarter
Turnover:
Employees: 1
Average salary: 715 €
A-Firmad OÜ
......
BIOREGULATOR ANTI AGING OÜ
History of right of representation?
Field
Health Care
Business age
8y
Beneficial country:
Sweden
Werner Günter Ulrich ... - ...
Liis Männiste ... - ...
Liis Männiste ... - ...
A-Firmad OÜ ... - ...
2016
2017
2019
2020
2021
2022
2024
2025
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
BIOREGULATOR ANTI AGING OÜ
Owners?
Former owners
BIOREGULATOR ANTI AGING OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... |
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
BIOREGULATOR ANTI AGING OÜ
GoodwillBIOREGULATOR ANTI AGING OÜ
Taxes paid and estimated average salariesBIOREGULATOR ANTI AGING OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
BIOREGULATOR ANTI AGING OÜ
Sales revenue by business areaBIOREGULATOR ANTI AGING OÜ
Sales revenue by countryBIOREGULATOR ANTI AGING OÜ
Financial indicators and prognosisBIOREGULATOR ANTI AGING OÜ
Financial raiting: "GOOD" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
BIOREGULATOR ANTI AGING OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 14.08.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 14.06.2023 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 20.06.2022 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 27.04.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 02.02.2021 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 12.09.2019 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 20.02.2019 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 05.09.2017 | ...... |
Liabilities and debts
BIOREGULATOR ANTI AGING OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
BIOREGULATOR ANTI AGING OÜ
Reports and assets-liabilities overview 18.03.2025?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
BIOREGULATOR ANTI AGING OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
BIOREGULATOR ANTI AGING OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
BIOREGULATOR ANTI AGING OÜ
Bailiff's enforcement proceedings as of 18.03.2025?
Bailiff's enforcement proceedings MISSING
BIOREGULATOR ANTI AGING OÜ
Regulations of the Payment Order Department as of 18.03.2025?
Regulations of the Payment Order Department MISSING
BIOREGULATOR ANTI AGING OÜ
Court orders in the register as of 18.03.2025?
Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata
11.07.2024
Regulation number: Ä 50026704 / M1
Regulation status has entered into force: 11.07.2024
Date of enforcement of order or additional period: 11.07.2024
Regulation status: Jõustunud
BIOREGULATOR ANTI AGING OÜ
Decisions of the Consumer Disputes Committee as of 18.03.2025?
Consumer disputes MISSING
BIOREGULATOR ANTI AGING OÜ
Court hearings as of 18.03.2025?
Court hearings MISSING
BIOREGULATOR ANTI AGING OÜ
Rulings as of 18.03.2025?
Court settlemets MISSING
BIOREGULATOR ANTI AGING OÜ
Notices and announcements as of 18.03.2025?
Announcements MISSING
Marketing
Business network
BIOREGULATOR ANTI AGING OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
BIOREGULATOR ANTI AGING OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.